Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
2017603 citationsThomas T. Warner, Patricia Limousin et al.profile →
Structures of α-synuclein filaments from human brains with Lewy pathology
2022262 citationsPatrick W. Cullinane, Thomas T. Warner et al.profile →
Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease
2019200 citationsEduardo De Pablo‐Fernández, Andrew J. Lees et al.profile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Thomas T. Warner
Since
Specialization
Citations
This map shows the geographic impact of Thomas T. Warner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas T. Warner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas T. Warner more than expected).
Fields of papers citing papers by Thomas T. Warner
This network shows the impact of papers produced by Thomas T. Warner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas T. Warner. The network helps show where Thomas T. Warner may publish in the future.
Co-authorship network of co-authors of Thomas T. Warner
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas T. Warner.
A scholar is included among the top collaborators of Thomas T. Warner based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Thomas T. Warner. Thomas T. Warner is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Lynham, Steven, et al.. (2016). A comprehensive characterisation of the salivary proteome of patients with Parkinson's disease. UCL Discovery (University College London).1 indexed citations
Klingelhoefer, Lisa, Thomas T. Warner, Davide Martino, et al.. (2014). Evaluation of the use of a dystonia non motor symptom questionnaire for craniocervical dystonia in the outpatient clinic. UCL Discovery (University College London).3 indexed citations
Warner, Thomas T., et al.. (2011). Generation of iPS-derived dopaminergic neurons as an in-vitro model of Rapid-Onset Dystonia Parkinsonism. UCL Discovery (University College London).1 indexed citations
17.
Wu, Wanli, Yubao Liu, Ming Ge, et al.. (2010). Application of a K-Nearest Neighbor Simulator for Seasonal Precipitation Prediction in a Semiarid Region with Complex Terrain. EGU General Assembly Conference Abstracts. 5237.1 indexed citations
18.
Warner, Thomas T., et al.. (2006). Strategy for a Game-based Simulation to Transform Global Business Processes. EdMedia: World Conference on Educational Media and Technology. 2006(1). 977–983.
19.
Tabrizi, Sarah J., et al.. (2004). High dose creatine therapy for Huntington's disease: Clinical and 31 phosphorous magnetic resonance spectroscopy ((31P) MRS) findings in a 2-year study. UCL Discovery (University College London).1 indexed citations
20.
Warner, Thomas T.. (1999). Sex-related influences on the frequency and age of onset of primary dystonia. Epidemiologic Study of Dystonia in Europe (ESDE) Collaborative Group.. UCL Discovery (University College London).25 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.